Your browser doesn't support javascript.
loading
Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis.
Wang, Xiuli; Zhao, Baoshan; Ren, Dan; Hu, Xiaolei; Qiao, Juanjuan; Zhang, Dongmei; Zhang, Yanzhi; Pan, Yu; Fan, Yuhua; Liu, Lili; Wang, Xiaoxue; Ma, Huanhuan; Jia, Xueling; Song, Sihang; Zhao, Chong; Liu, Jingbo; Wang, Lin.
Affiliation
  • Wang X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Zhao B; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Ren D; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Hu X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Qiao J; Department of Pathology, Daqing Longnan Hospital, Daqing, Heilongjiang, China.
  • Zhang D; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Zhang Y; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Pan Y; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Fan Y; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Liu L; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Wang X; Department of Anatomy, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Ma H; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Jia X; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Song S; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Zhao C; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Liu J; Department of Pathology and Pathophysiology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
  • Wang L; Department of Histology and Embryology, Harbin Medical University-Daqing, Daqing, Heilongjiang, China.
Cancer Biomark ; 38(2): 191-201, 2023.
Article de En | MEDLINE | ID: mdl-37545227
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénocarcinome pulmonaire / Tumeurs du poumon Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Cancer Biomark Sujet du journal: BIOQUIMICA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adénocarcinome pulmonaire / Tumeurs du poumon Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Cancer Biomark Sujet du journal: BIOQUIMICA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas